Skip to content

Eqwal Brussels: what changed

BE 0422.269.803NACE 47.741, Retail sale of medical and orthopaedic goods, excluding prescription glasses and lensesOther company

Position among the sector peers

What moved between 30-09-2024 and 30-09-2025

Net result for the year
-€80,052
30-09-2024 · €35,357-€115,409
Equity
€340,673
30-09-2024 · €421,532-€80,859
Cash
€104,496
30-09-2024 · €124,030-€19,534
Balance sheet total
€732,936
30-09-2024 · €789,133-€56,197

Largest movements

30-09-2024 to 30-09-2025
Assets
  • Tangible fixed assets -€60,117

    down €60,117 (-39.4%), from €152,670 to €92,553

    of which Plant, machinery and equipment: -€53,323

  • Receivables within one year +€34,436

    up €34,436 (+11.7%), from €294,511 to €328,947

    of which Trade receivables: +€85,977

  • Stocks and contracts -€27,362

    down €27,362 (-13.1%), from €209,229 to €181,867

  • Cash -€19,534

    down €19,534 (-15.7%), from €124,030 to €104,496

    mainly Net result for the year (-€80,052) and Tax, wage and social debts (-€54,021)

  • Deferred charges and accrued income +€9,781

    up €9,781 (+116%), from €8,453 to €18,234

Equity and liabilities
  • Profit (loss) carried forward -€80,051

    down €80,051 (-34.7%), from €230,703 to €150,652

  • Tax, wage and social debts -€54,021

    down €54,021 (-26.3%), from €205,701 to €151,680

    of which Taxes: -€55,627

  • Other debts +€47,967

    up €47,967 (+2,225%), from €2,156 to €50,123

  • Trade debts +€40,500

    up €40,500 (+30.5%), from €132,806 to €173,306

  • Debts after one year -€13,456

    no longer reported in 2025 (was €13,456)

Income statement
  • Gross operating margin -€102,713

    down €102,713 (-15.6%), from €657,419 to €554,706

  • Staff costs +€69,380

    up €69,380 (+13.5%), from €515,266 to €584,646

  • Taxes -€68,852

    down €68,852, from €48,411 to -€20,441

  • Write-downs +€11,369

    no longer reported in 2025 (was -€11,369)

Change in the result, 30-09-2024 to 30-09-2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 30-09-2024 €35,357
Gross operating margin -€102,713
Staff costs -€69,380
Depreciation +€717
Write-downs -€11,369
Other operating charges -€1,285
Other operating items -€3
Financial income -€588
Financial charges +€362
Taxes +€68,852
Result 30-09-2025 -€80,052
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 30-09-2024 to 30-09-2025

The bridge is derived from the 30-09-2024 and 30-09-2025 balance sheets and the 30-09-2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€835
Investment -€6,274
Financing -€14,096
Cash 30-09-2024 €124,030
Net result for the year -€80,052
Depreciation +€59,791
Stocks and contracts +€27,362
Receivables within one year -€34,436
Deferred charges and accrued income -€9,781
Trade debts +€40,500
Tax, wage and social debts -€54,021
Advances received +€3,699
Other debts +€47,967
Accrued charges and deferred income -€194
Investment in fixed assets (net) -€6,274
Debts after one year -€13,456
Current portion of long-term debt +€168
Contributions, distributions and other -€808
Cash 30-09-2025 €104,496
brings cash intakes cash out
Every line side by side 50 lines
Line Code 30-09-2024 30-09-2025 Change %
Total assets 20/58 €789,133 €732,936 -€56,197 -7.1%
Fixed assets 21/28 €152,910 €99,393 -€53,517 -35.0%
Intangible fixed assets 21 - €6,599 +€6,599
Tangible fixed assets 22/27 €152,670 €92,553 -€60,117 -39.4%
Plant, machinery and equipment 23 €118,264 €64,941 -€53,323 -45.1%
Furniture and vehicles 24 €34,406 €27,612 -€6,794 -19.7%
Financial fixed assets 28 €240 €240 = 0.0%
Current assets 29/58 €636,223 €633,544 -€2,679 -0.4%
Stocks and contracts in progress 3 €209,229 €181,867 -€27,362 -13.1%
Stocks 30/36 €209,229 €181,867 -€27,362 -13.1%
Amounts receivable within one year 40/41 €294,511 €328,947 +€34,436 +11.7%
Trade receivables 40 €242,013 €327,990 +€85,977 +35.5%
Other amounts receivable 41 €52,498 €956 -€51,542 -98.2%
Cash at bank and in hand 54/58 €124,030 €104,496 -€19,534 -15.7%
Deferred charges and accrued income 490/1 €8,453 €18,234 +€9,781 +116%
Total equity and liabilities 10/49 €789,133 €732,936 -€56,197 -7.1%
Equity 10/15 €421,532 €340,673 -€80,859 -19.2%
Contributions 10/11 €68,593 €68,593 -€0 0.0%
Reserves 13 €119,404 €119,404 +€0 0.0%
Distributable reserves 133 €119,404 €119,404 +€0 0.0%
Profit (loss) carried forward 14 €230,703 €150,652 -€80,051 -34.7%
Investment grants 15 €2,832 €2,024 -€808 -28.5%
Amounts payable 17/49 €367,601 €392,264 +€24,663 +6.7%
Amounts payable after more than one year 17 €13,456 - -€13,456
Financial debts 170/4 €13,456 - -€13,456
Amounts payable within one year 42/48 €353,951 €392,264 +€38,313 +10.8%
Current portion of amounts payable after more than one year 42 €13,288 €13,456 +€168 +1.3%
Trade debts 44 €132,806 €173,306 +€40,500 +30.5%
Suppliers 440/4 €132,806 €173,306 +€40,500 +30.5%
Advances received on contracts in progress 46 - €3,699 +€3,699
Taxes, remuneration and social security 45 €205,701 €151,680 -€54,021 -26.3%
Taxes 450/3 €67,148 €11,521 -€55,627 -82.8%
Remuneration and social security 454/9 €138,553 €140,159 +€1,606 +1.2%
Other amounts payable 47/48 €2,156 €50,123 +€47,967 +2,225%
Accrued charges and deferred income 492/3 €194 - -€194
Remuneration, social security and pensions 62 €515,266 €584,646 +€69,380 +13.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €60,508 €59,791 -€717 -1.2%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€11,369 - +€11,369
Other operating charges 640/8 €3,376 €4,661 +€1,285 +38.1%
Non-recurring operating charges 66A - €3 +€3
Gross operating margin 9900 €657,419 €554,706 -€102,713 -15.6%
Operating profit (loss) 9901 €89,638 -€94,396 -€184,034
Financial income 75/76B €1,917 €1,329 -€588 -30.7%
Recurring financial income 75 €1,917 €1,329 -€588 -30.7%
Financial charges 65/66B €7,787 €7,425 -€362 -4.6%
Recurring financial charges 65 €7,787 €7,425 -€362 -4.6%
Profit (loss) for the period before taxes 9903 €83,768 -€100,492 -€184,260
Income taxes 67/77 €48,411 -€20,441 -€68,852
Profit (loss) for the period 9904 €35,357 -€80,052 -€115,409
Profit (loss) for the period to be appropriated 9905 €35,357 -€80,052 -€115,409

Value

latest balance sheet 30-09-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€334,073 to €334,073

Midpoint €334,073 · adjusted equity only

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €334,073
Indication €334,073

Adjusted equity

balance sheet 30-09-2025
Equity (10/15)
€340,673
Intangible fixed assets (21)
-€6,599
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€334,073

Capitalised earnings

net result for the year (9904)
2025
-€80,052
excluding non-recurring income and charges
-€80,049
2024
€35,357
2023
€4,447
2023
€157,673
2022
€58,945
Average result, excluding non-recurring income and charges
-€13,415
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 13 November 2026 via checked.be.